| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/28/2011 | CN102202662A Agent for treatment of diabetes |
| 09/28/2011 | CN102202658A Compound for local deletion of tumors |
| 09/28/2011 | CN102202653A Nanoparticles for immunotherapy |
| 09/28/2011 | CN102199628A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 09/28/2011 | CN102199608A Efficient expression of pinellia ternate agglutinin (PTA) in bombyx mori reactor |
| 09/28/2011 | CN102199603A Multi-target interfering RNA (Ribonucleic Acid) molecule and application thereof |
| 09/28/2011 | CN102199587A Functional mutant of human plasminogen, its preparation method and application |
| 09/28/2011 | CN102199226A Method for extracting peanut polysaccharides from hot pressed peanut meal |
| 09/28/2011 | CN102199218A Fusion protein of Her2 antibody and interleukin 2 and application thereof |
| 09/28/2011 | CN102199216A New dendritic cell co-stimulatory molecules |
| 09/28/2011 | CN102199199A Membrane localization staphylococcal enterotoxin A and gene sequence thereof |
| 09/28/2011 | CN102199184A Hederasaponin derivative, preparation method of salts thereof and application thereof to resisting tumor |
| 09/28/2011 | CN102199155A Method for preparing humantenmine from elegant Jessamine extracts |
| 09/28/2011 | CN102199152A Heterocycle imidazoles phosphatide kinases inhibitor |
| 09/28/2011 | CN102199150A Optical active oxazolidinone derivatives as well as preparation methods and application to preparing medicaments |
| 09/28/2011 | CN102199148A Benzsulfamide derivatives and medicinal composition thereof |
| 09/28/2011 | CN102199134A Thiadiazole histone deacetylase inhibitors and application thereof |
| 09/28/2011 | CN102199121A 4-(4-(3-trifluoro methyl) benzamido phenoxyl)-2-(methyl carbamyl) pyridine salt, its preparation method and application |
| 09/28/2011 | CN102199116A Fluoro imido sugar compounds, and preparation method and application thereof |
| 09/28/2011 | CN102199113A Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds |
| 09/28/2011 | CN102199079A Phenol compound and preparation method and application thereof |
| 09/28/2011 | CN102198277A Dual-targeting gene treatment vector for liver cancer and preparation method thereof |
| 09/28/2011 | CN102198276A Application of chylomicron as liver targeting gene treatment vector |
| 09/28/2011 | CN102198266A Cancer antigens based on tumor suppressor gene WT1 product |
| 09/28/2011 | CN102198263A Application of ipomoea batatas Sporamin protein in preparation of medicines for treating and preventing tumours and health products |
| 09/28/2011 | CN102198249A Chinese herbal medicine preparation for treating cancers |
| 09/28/2011 | CN102198243A Oviduct dredging medicament for removing blood stasis and warming meridians |
| 09/28/2011 | CN102198242A Traditional Chinese medicine composition for treating hysteromyoma |
| 09/28/2011 | CN102198231A Method for extracting ceramide-rich lipid from byproducts of agriculture and forestry by supercritical extraction technology |
| 09/28/2011 | CN102198226A Chinese herbal medicine composition for treating cancer |
| 09/28/2011 | CN102198218A Radix hedysari and cordyceps compound fine flour capsule and preparation method thereof |
| 09/28/2011 | CN102198210A Quality control method of xiaojiean preparation |
| 09/28/2011 | CN102198198A Tea drink for treating cancer |
| 09/28/2011 | CN102198189A Preparation method of low-caffeine tea extract |
| 09/28/2011 | CN102198163A Preparation method of feverfew extractive |
| 09/28/2011 | CN102198150A Antitumor drug with double active components and application thereof |
| 09/28/2011 | CN102198142A Anti-tumour compounds with angeloyl groups |
| 09/28/2011 | CN102198139A Pharmaceutical composition with antineoplastic effect, and application method thereof |
| 09/28/2011 | CN102198125A Purpose of phenethyl caffeate derivatives in preparation of medicines for inhibiting angiogenesis of tumors |
| 09/28/2011 | CN102198121A Application of 2, 2, 3, 3- tetramethyl cyclopropyl carbonyl thiourea in the process for preparing antitumor medicine |
| 09/28/2011 | CN102198117A Thermosensitive polymeric microcapsules and preparation method and use thereof |
| 09/28/2011 | CN102198115A Enteric-coated micro-capsule prepared by mixing traditional Chinese medicine extract and probitics |
| 09/28/2011 | CN102198101A 10-hydroxycamptothecine invisible nano-particle sustained release preparation and preparation method thereof |
| 09/28/2011 | CN102198100A Carmustine powder injection and preparation technology thereof |
| 09/28/2011 | CN102198096A ACA (acetoxychavicol acetate) submicron emulsion for intravenous injection, and preparation method and application thereof |
| 09/28/2011 | CN102198085A Triblock copolymer micelle and freeze-drying preparation loading taxane medicaments, and preparation method and application thereof |
| 09/28/2011 | CN102198084A Paclitaxel mixed micelle preparation, and preparation method thereof |
| 09/28/2011 | CN102198083A Micelles and freeze-dried preparations of diblock polymer-supported taxane medicines and preparation and use thereof |
| 09/28/2011 | CN102198080A Adriamycin sustained-release medicinal rod for treating Cerebral gliomas disease and preparation method thereof |
| 09/28/2011 | CN102000085B Medicament for treating breast cancer and preparation method thereof |
| 09/28/2011 | CN101961363B Preparation method of active pseudo-ginseng slices |
| 09/28/2011 | CN101940699B Traditional Chinese medicine for assisting in treating liver cancer |
| 09/28/2011 | CN101940548B Oral fluorouracil emulsion and preparation method thereof |
| 09/28/2011 | CN101926775B Preparation and application methods of difunctional naonparticle preparation entrapping vincristine sulphate |
| 09/28/2011 | CN101897908B Traditional Chinese medicine composition for treating cirrhosis ascites and liver cancer and preparation method thereof |
| 09/28/2011 | CN101891738B Dasatinib polymorph and preparation method and medical composition thereof |
| 09/28/2011 | CN101869587B Method for extracting anti-gastric cancer active component from water chestnut shells |
| 09/28/2011 | CN101797340B Composite drug for curing esophageal carcinoma and preparation method thereof |
| 09/28/2011 | CN101759699B Pyrro-perhydroazepinone compound and application thereof in preparing medicaments for treating tumors |
| 09/28/2011 | CN101732238B 丝裂霉素c眼用凝胶剂 Mitomycin c eye gel |
| 09/28/2011 | CN101723906B Compound, medical composition containing same as well as preparation method and application |
| 09/28/2011 | CN101633637B 8-oxo-8H-acenaphtho[1,2-b]pyrrole derivative |
| 09/28/2011 | CN101618066B Preparation method of walnut green husk total tannin and application of same |
| 09/28/2011 | CN101618016B Method for preparing W/O/W type compound emulsion embedding chlorogenic acid, product and application of W/O/W type compound emulsion |
| 09/28/2011 | CN101606934B Bendamustine hydrochloride compound |
| 09/28/2011 | CN101597291B 2-aminoacyl tryptophyl-Beta-tetrahydric carboline-3-carboxylic acid carbobenzoxy as well as preparation method and application thereof |
| 09/28/2011 | CN101570755B Novel gene of virus original protease inhibitor as well as expression and application thereof |
| 09/28/2011 | CN101564381B Gemcitabine hydrochloride lyophilized powder injection |
| 09/28/2011 | CN101524529B Treatment on human malignant solid tumor by HNF4 alpha inducement and differentiation |
| 09/28/2011 | CN101513515B Chinese patent drug for treatment of lung cancer |
| 09/28/2011 | CN101491563B Ginseng and pilose antler oral preparation and preparation method thereof |
| 09/28/2011 | CN101474415B RGD polypeptide radiopharmaceutical for integrin alphav beta3 positive tumor and preparation method thereof |
| 09/28/2011 | CN101444597B Chinese herbal medicine for treating tumor |
| 09/28/2011 | CN101391070B Quality control method of traditional Chinese medicine composition with anti-tumor action |
| 09/28/2011 | CN101374840B 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors |
| 09/28/2011 | CN101333531B CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
| 09/28/2011 | CN101327307B Medicament for treating cancer and preparation method |
| 09/28/2011 | CN101326182B 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors |
| 09/28/2011 | CN101307094B Novel nuclear factor -kappa B p65 subunit antagonizing polypeptide |
| 09/28/2011 | CN101160303B 1-(2H)-isoquinolone derivative |
| 09/27/2011 | US8026341 Transfection complexes |
| 09/27/2011 | US8026276 Parenteral CCI-779 formulations containing cosolvents, an antioxidant, and a surfactant |
| 09/27/2011 | US8026273 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient |
| 09/27/2011 | US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 09/27/2011 | US8026216 Using endothelin B (ETB) agonist to enhance the delivery and resulting efficacy of chemotherapeutic agent; antitumor agents |
| 09/27/2011 | US8026213 Methods for treating muscle diseases and disorders |
| 09/27/2011 | US8026072 Method of identifying compounds that bind BAFF-R |
| 09/27/2011 | US8025893 Cyclopamine can be used for obtaining decrease of pigmentation of hyperpigmented skin areas |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/27/2011 | CA2676424C Taxane derivatives and processes for the preparation thereof |
| 09/27/2011 | CA2658462C Substituted pyridone compounds and methods of use |
| 09/27/2011 | CA2649753C Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| 09/27/2011 | CA2608848C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/27/2011 | CA2531620C Cancer combination therapy comprising azd2171 and zd1839 |
| 09/27/2011 | CA2506476C Method of treatment of myocardial infarction |
| 09/27/2011 | CA2493815C Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 09/27/2011 | CA2475930C 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 09/27/2011 | CA2467723C Method for treating cervical cancer |
| 09/27/2011 | CA2453486C The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 09/27/2011 | CA2440630C Metalloproteinase inhibitors |